Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Khiron Life Sciences Corp. („Khiron" oder das „Unternehmen") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC) gibt bekannt, dass es im Rahmen des von...
Following the Government of Colombia's decision on insurance coverage for medical cannabis, Khiron has begun dispensing medical cannabis to its...
Zerenia™ Clinics UK, eine hundertprozentige Tochtergesellschaft von Khiron, hat die Erstattung der Kosten für die cannabisbasierte Behandlung und der ...
Zerenia™ Clinics UK, wholly owned by Khiron, succeeds at having the NHS reimbursing both the cost of cannabis-based treatment and clinic fees to its...
Am 27. Dezember 2022 unterzeichnete Zerenia (ein in Khirons hundertprozentigem Eigentum befindliches Netzwerk medizinischer Cannabiskliniken) einen...
On December 27, 2022, Zerenia (Khiron´s wholly owned medical cannabis clinic network) signed a contract with CAPITAL SALUD EPS, Colombia´s largest...
Am 30. Dezember 2022 bekräftigte das kolumbianische Gesundheitsministerium die Aufnahme von medizinischen Cannabisprodukten auf Pflanzenbasis, d. h....
On December 30, 2022, the Ministry of Health of Colombia reaffirmed the inclusion of plant-based medical cannabis products, i.e., Khiron products, in ...
In Europa stieg der Umsatz im Jahresvergleich um 141 %, befördert durch den Umsatz im Vereinigten Königreich, wo das Unternehmen jetzt sein...
In Europe, revenues increased by 141% year-over-year, driven by revenues in the United Kingdom, where the Corporation is now increasing its existing...
TORONTO, Nov. 18, 2022 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMXC), the...
Through its newly acquired EU-GMP distribution hub in Germany, Khiron expands its product portfolio and geographic reach within Europe to Germany,...
TORONTO, Sept. 13, 2022 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a...
New products to be distributed through Khiron's new wholly-owned subsidiary Pharmadrug Production GmbH Khiron introduces new THC-dominant...
Reports revenues of $9.1 million in the first half of 2022, up 62% year-over-year, reflecting continued medical cannabis momentum in target markets...
TORONTO, Aug. 22, 2022 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN)(OTCQX: KHRNF)(Frankfurt: A2JMXC), the...
Crescimento global contínuo da Clínica modelo ZereniaTM da Khiron com foco em pacientes, formação de médicos e inovação A nova clínica fica no bairro ...
Continued Global Growth of Khiron's Proven ZereniaTM Clinic Model Focused on Patients, Physician Education and Innovation New clinic is in the...
Durch die Akquisition erhält Khiron ein europäisches EU-GMP-Herstellungs- und Vertriebszentrum für medizinisches Cannabis und andere pharmazeutische...
Acquisition provides Khiron with an EU-GMP European manufacturing and distribution hub for medical cannabis and other pharmaceutical products The...
TORONTO, July 18, 2022 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a...
Khirons medizinische Kliniken und Vertriebswachstum in ganz Europa folgen auf Erfolge auf dem lateinamerikanischen Markt Seit der Gründung einer...
Khiron's Medical Clinics and Distribution Growth Throughout Europe Follows Success in Latin American Marketplace Since establishing a Spanish...
Khiron Serves Record Number of Patients With Khiron Products Globally in Its Medical Treatment Clinics TORONTO, June 28, 2022 /PRNewswire/ - Khiron...
TORONTO, June 23, 2022 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.